Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02823327 · ADVERSE EVENTS

Adverse events

Clinical and Genomic Factors for Prognosis of AIDS Primary Effusion Lymphoma · Source last updated 2025-05-11

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.

Collection time frame
This study is a retrospective, chart-review study. The time frame for evaluating adverse event is not applicable.
Other-event reporting threshold
0%

This study is a retrospective, chart-review study. Death and Adverse Events were not assessed. The adverse event report is not relevant. Since this is not an interventional study, the adverse event report is not relevant.

Participants affected / participants at risk, as reported
Safety groupSerious eventsOther eventsDeaths
Chart Review, RNA Sequencing, Microarray

Laboratory Biomarker Analysis. Medical chart review is performed and patient information is collected regarding human immunodeficiency virus HIV/AIDS medical history, staging of AIDS related malignancy, and type of treatment. Previously collected tissue samples are analyzed via RNA sequencing and microarray. Laboratory Biomarker Analysis: Correlative studies Medical Chart Review: Medical chart review is performed

0 / 00 / 00 / 0

Group identifiers: EG000: Chart Review, RNA Sequencing, Microarray

Serious adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

    Other reported adverse events

    Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

      Complete source fields
      description
      This study is a retrospective, chart-review study. Death and Adverse Events were not assessed. The adverse event report is not relevant. Since this is not an interventional study, the adverse event report is not relevant.
      event Groups
      1. deaths Num Affected
        0
        deaths Num At Risk
        0
        description
        Laboratory Biomarker Analysis. Medical chart review is performed and patient information is collected regarding human immunodeficiency virus HIV/AIDS medical history, staging of AIDS related malignancy, and type of treatment. Previously collected tissue samples are analyzed via RNA sequencing and microarray. Laboratory Biomarker Analysis: Correlative studies Medical Chart Review: Medical chart review is performed
        id
        EG000
        other Num Affected
        0
        other Num At Risk
        0
        serious Num Affected
        0
        serious Num At Risk
        0
        title
        Chart Review, RNA Sequencing, Microarray
      frequency Threshold
      0
      time Frame
      This study is a retrospective, chart-review study. The time frame for evaluating adverse event is not applicable.

      Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

      Preserved source evidence · Not medical advice